Zainulabid, U. A. (2024). The persistence of antibodies in ESRD patients 12 months after the BNT162B2 vaccine booster dose. UniKL Royal College of Medicine Perak (UniKL RCMP).
استشهاد بنمط شيكاغوZainulabid, Ummu Afeera. The Persistence of Antibodies in ESRD Patients 12 Months After the BNT162B2 Vaccine Booster Dose. UniKL Royal College of Medicine Perak (UniKL RCMP), 2024.
MLA استشهادZainulabid, Ummu Afeera. The Persistence of Antibodies in ESRD Patients 12 Months After the BNT162B2 Vaccine Booster Dose. UniKL Royal College of Medicine Perak (UniKL RCMP), 2024.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.